Phibro Animal Health Corporation Class A PAHC 深 滬
已收盤 02-06 16:00:00 美东时间
53.07
+3.070
+6.14%
華盛通- 最 高56.30
- 今 開50.75
- 成交量 64.68万股
- 最 低 50.2601
- 昨 收 50.00
- 總市值 21.51亿
- 52周最高 56.30
- 市盈率 靜 44.73
- 換手率 1.60%
- 52周最低 15.80
- 委 比 91.67%
- 總股本 4053.47万
- 歷史最高 56.30
- 量 比 1.56
- 振 幅 12.08%
- 歷史最低 8.32
- 每 手 1
- 風險率 8.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | 光通信龙头Lumentum业绩炸裂！周内飙涨逾40%；创新药公司MANE上市股价即翻倍
光通信龙头Lumentum业绩炸裂！周内股价飙涨逾40%；创新药公司MANE上市即翻倍，聚焦脱发口服药物；德州仪器75亿美元收编芯科实验室>>
02-07 11:39
美股牛股 | 绩优股飙升！精密计时龙头SiTime涨近18%，Q4财报超预期；麦克森药物批发涨超16%
绩优股飙升！精密计时龙头SiTime涨近18%，Q4财报超预期同时公布重大收购；麦克森药物批发涨超16%，26Q3业绩超预期；恩赛因绩后涨近14%>>
02-06 15:30
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Dow Jones index falling more than 350 points o...
02-06 01:07
Phibro Animal Health Raises FY2026 GAAP EPS Guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 GAAP EPS guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 analyst estimate..
02-05 05:28
Phibro Animal Health Earnings Review: Q2 Summary
Phibro Animal Health (NASDAQ:PAHC) reported its Q2 earnings results on Wednesda...
02-05 05:28
Phibro Animal Health Q2 Adj. EPS $0.87 Beats $0.67 Estimate, Sales $373.900M Beat $355.637M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.67 by 29.85 percent. This is a 58.18 percent increase over earnings of $0.55 per share
02-05 05:27
BRIEF-Phibro Animal Health Q2 Adjusted EBITDA USD 68.1 Million
BRIEF-Phibro Animal Health Q2 Adjusted EBITDA USD 68.1 Million Feb 04 (Reuters) - Phibro Animal Health Q2 sales USD 373.9 million. Q2 adjusted net income USD 35.7 million Q2 net income USD 27.5 million
02-05 05:25
Phibro Animal Health Declares Quarterly Cash Dividend
The latest update is out from Phibro Animal Health ( ($PAHC) ). On February 3, ...
02-04 05:58
Phibro Animal Health CEO Jack Bendheim Reports Sale of Common Shares
Phibro Animal Health CEO Jack Bendheim Reports Sale of Common Shares Jack Bendheim, President and CEO of Phibro Animal Health Corporation, reported a disposal of common shares of the company according to a recent SEC filing. The report was filed by Jack Bendheim, BFI Co., LLC, and other reporting be
02-03 05:15
Phibro Animal Health Corporation Files Initial Statement of Beneficial Ownership for Patrick Rodriguez, VP Finance and Treasurer
Phibro Animal Health Corporation Files Initial Statement of Beneficial Ownership for Patrick Rodriguez, VP Finance and Treasurer Phibro Animal Health Corporation has filed an initial statement of beneficial ownership (Form 3) with the U.S. Securities and Exchange Commission. The filing names Patrick
01-23 05:16
